Endologix Inc Quick Ratio (ELGX) starting from the second quarter 2020 to second quarter 2019, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Endologix Inc  (ELGX)

Endologix Inc's Quick Ratio

ELGX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2020, Quick Ratio fell to 0.09 a new company low.

Within Medical Equipment & Supplies industry 179 other companies have achieved higher Quick Ratio than Endologix Inc in second quarter 2020. While Quick Ratio total ranking has improved so far during the Q2 2020 to 4409, from total ranking in the first quarter 2020 at 4451.

Explain Quick Ratio?
How much Cash & cash equivalents ELGX´s has?
What are ELGX´s Current Liabilities?




ELGX Quick Ratio (Jun 30 2020)
Q2
(Mar 31 2020)
Q1
(Dec 31 2019)
Q4
(Sep 30 2019)
Q3
(Jun 30 2019)
Q2
Y / Y Current Liabilities Change 225.2 % 356.6 % 43.33 % -21.95 % 15.98 %
Y / Y Cash & cash equivalent Change -62.23 % 287.62 % 76.62 % 12.67 % 38.53 %
Quick Ratio MRQ 0.09 0.18 0.74 0.86 0.74
ELGX's Total Ranking # 4409 # 4451 # 2406 # 2236 # 1665
Seq. Current Liabilities Change 0.19 % 310.73 % 0.68 % -21.51 % 40.68 %
Seq. Cash & cash equivalent Change -53.37 % 1.62 % -13.03 % -8.35 % 378.55 %



Quick Ratio second quarter 2020 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 180
Healthcare Sector # 916
Overall Market # 4409


Quick Ratio Statistics
High Average Low
3.88 1.66 0.09
(Jun 30 2014)   (Jun 30 2020)




Financial Statements
Endologix Inc's Current Liabilities $ 230 Millions Visit ELGX's Balance sheet
Endologix Inc's Cash & cash equivalent $ 20 Millions Visit ELGX's Balance sheet
Source of ELGX's Sales Visit ELGX's Sales by Geography


Cumulative Endologix Inc's Quick Ratio

ELGX's Quick Ratio for the trailling 12 Months

ELGX Quick Ratio

(Jun 30 2020)
12 Months
(Mar 31 2020)
12 Months
(Dec 31 2019)
12 Months
(Sep 30 2019)
12 Months
(Jun 30 2019)
12 Months
Y / Y Current Liabilities TTM Growth 147.04 % 85.97 % 0.27 % -14.99 % -2.47 %
Y / Y Cash & cash equivalent TTM Growth 17.28 % 60.49 % -0.84 % -29.56 % -42.75 %
Quick Ratio TTM 0.27 0.45 0.66 0.62 0.56
Total Ranking TTM # 4952 # 4675 # 4625 # 4526 # 4654
Seq. Current Liabilities TTM Growth 38.69 % 77.14 % 7.84 % -6.76 % 4.4 %
Seq. Cash & cash equivalent TTM Growth -17.66 % 20.57 % 13.42 % 4.17 % 12.67 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2020 to $229.60 millions, cumulative Quick Ratio decreased to 0.27 below the Endologix Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Endologix Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2020 from 4675 to 4952.

Explain Quick Ratio?
How much Cash & cash equivalents ELGX´s has?
What are ELGX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 946
Within the Market # 4952


trailing twelve months Quick Ratio Statistics
High Average Low
3.23 1.55 0.27
(Mar 31 2015)   (Jun 30 2020)




Companies with similar Quick Ratio in the quarter ending Jun 30 2020, within Medical Equipment & Supplies Industry Quick RatioJun 30 2020 MRQ Cash & cash equivalentJun 30 2020 MRQ Current Liabilities
Vaso Corporation  0.23 $ 6.944  Millions$ 29.822  Millions
Vivos Inc  0.23 $ 0.249  Millions$ 1.084  Millions
Enovis Corp  0.20 $ 66.396  Millions$ 339.828  Millions
Electromedical Technologies Inc   0.18 $ 0.127  Millions$ 0.710  Millions
Fuse Medical Inc   0.18 $ 1.167  Millions$ 6.543  Millions
The Pennant Group Inc   0.15 $ 12.129  Millions$ 80.461  Millions
Patterson Companies Inc   0.13 $ 119.561  Millions$ 947.584  Millions
The Cooper Companies Inc   0.12 $ 127.400  Millions$ 1,096.400  Millions
Petvivo Holdings Inc   0.09 $ 0.138  Millions$ 1.465  Millions
Odyssey Health Inc   0.09 $ 0.063  Millions$ 0.707  Millions
Gi Dynamics Inc   0.09 $ 0.733  Millions$ 8.281  Millions
Guided Therapeutics Inc   0.09 $ 0.763  Millions$ 8.630  Millions
Endologix Inc  0.09 $ 19.696  Millions$ 229.598  Millions
Vystar Corporation  0.07 $ 0.943  Millions$ 13.103  Millions
Biotricity Inc   0.06 $ 0.224  Millions$ 3.821  Millions
Legacy Ventures International Inc  0.06 $ 0.015  Millions$ 0.271  Millions
Intelligent Bio Solutions Inc   0.05 $ 0.427  Millions$ 8.478  Millions
Stimcell Energetics Inc   0.05 $ 0.045  Millions$ 0.943  Millions
Premier Air Charter Holdings Inc   0.05 $ 0.004  Millions$ 0.079  Millions
Nutriband Inc   0.05 $ 0.039  Millions$ 0.868  Millions
Icu Medical Inc  0.04 $ 14.564  Millions$ 359.151  Millions
Imaging Diagnostic Systems Inc  0.04 $ 0.046  Millions$ 1.189  Millions
Quantrx Biomedical Corporation  0.04 $ 0.083  Millions$ 2.336  Millions
3m Company  0.03 $ 247.000  Millions$ 7,282.000  Millions
Remedent Inc   0.03 $ 0.096  Millions$ 2.863  Millions
Vycor Medical Inc   0.03 $ 0.077  Millions$ 2.584  Millions
Sanuwave Health Inc   0.03 $ 0.431  Millions$ 15.299  Millions
Infusystem Holdings Inc  0.02 $ 0.482  Millions$ 20.117  Millions

Date modified: 2026-09-08T15:10:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.